Effects of progestagen treatment on concentrations of prostaglandins and oxytocin in plasma from the posterior vena cava of post-partum beef cows

J Reprod Fertil. 1991 Mar;91(2):411-21. doi: 10.1530/jrf.0.0910411.

Abstract

The role of PGF-2 alpha in determining the lifespan of corpora lutea in the post-partum beef cow was investigated. In control cows (N = 5) induced to ovulate at Day 28 to 36 post partum by injection of 1000 i.u. hCG, corpora lutea had an average lifespan of only 8 days. In cows pretreated with 6 mg implants of a progestagen (norgestomet, N = 4) for 9 days, with implant removal 2 days before injection of hCG, luteal lifespan averaged 17.5 days. Concentrations of PGF-2 alpha in 9 hourly samples of plasma collected from the posterior vena cava via indwelling catheters were higher on Days 4 through 9 after injection of hCG (P less than 0.05) in the cows with short-lived corpora lutea. Greater release of PGF-2 alpha could therefore be a major factor in premature luteal regression. Concentrations of PGFM and oxytocin did not differ between cows with corpora lutea of short or normal lifespan. In a second experiment, concentrations of PGF-2 alpha in plasma from the posterior vena cava were examined during treatment with norgestomet (N = 8) or in contemporary controls (N = 7). In progestagen-treated cows, PGF-2 alpha was higher than in control cows (P less than 0.05), beginning on Day 3 of treatment and peaking on Day 5. It is concluded that the post-partum uterus increases secretion of PGF-2 alpha very early after first exposure to endogenous or exogenous progestagen.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cattle
  • Chorionic Gonadotropin / pharmacology
  • Corpus Luteum / drug effects
  • Dinoprost / analogs & derivatives
  • Dinoprost / blood*
  • Dinoprost / metabolism
  • Female
  • Luteolysis / physiology
  • Oxytocin / blood*
  • Postpartum Period / blood*
  • Pregnancy
  • Pregnenediones / pharmacology*
  • Progesterone Congeners / pharmacology*
  • Radioimmunoassay
  • Uterus / metabolism
  • Vena Cava, Inferior

Substances

  • Chorionic Gonadotropin
  • Pregnenediones
  • Progesterone Congeners
  • 15-keto-13,14-dihydroprostaglandin F2alpha
  • norgestomet
  • Oxytocin
  • Dinoprost